Future Strategies Against Emerging and Evolving Pathogens: Lessons From COVID-19

Authors: Robert Carnahan, Lauriane Cabon, Kyoji Tsuchikama, Jerry Madukwe | Last updated: [30/08/2022]


Antibody-based therapeutics hold great promise in treatment and prevention of multiple diseases such as cancer and infectious diseases. Effective assays for functional characterization of antibody-based therapeutics are critical due to the time- and resource- consuming process of antibody-based therapeutics discovery.

In our on-demand webinar, we discuss recent advances in assay systems in the functional characterization of antibody-based therapeutics. Hear from experts in the field working on antibody-drug conjugates (ADCs), T-cell bispecifics, and other antibody discovery programs.

  • Document type: Webinar
  • Page count: 12
  • Read time: Approx. 1 hour

Complete the Form to Access the Webinar

Key Takeaways

  • Cell-based platform for rapid antiviral therapeutic antibody discovery and characterization
  • 3D culture platforms for predicting toxicity of cancer antibody-based therapeutics
  • Using live-cell assays optimize ADC-based chemotherapies

This Resource is Designed for:

  • Scientists, Lab technicians and Lab manager at  Biopharma,/Pharma small Biotech & also large Academic institutions as well as university research centers,  working on solutions for combat the COVID-19 pandemic and further researches around infectious diseases

Applications Supported:

  • Vaccines and Therapeutics for COVID-19

Request a Quote, Demo, or More Information

What other areas are you interested in? (select all that apply)

Please Complete the Form to Watch the Webinar